|
68-Gallium DOTATATE Clinical Trials
2 actively recruiting trials across 1 location
Pipeline
Phase 2: 1
Top Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
- National Cancer Institute (NCI)1
Indications
- Cancer2
- VHL Pancreatic Neuroendocrine Tumors1
- Tall Cell Variant Thyroid Cancer1
- Hurthle Cell Thyroid Cancer1
- Papillary Thyroid Cancer1
Bethesda, Maryland2 trials
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
National Institutes of Health Clinical Center
Phase 2
Studies on Tumors of the Thyroid
National Institutes of Health Clinical Center
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.